article thumbnail

Digital dilemma in UK’s life sciences job market

Pharmaceutical Technology

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

article thumbnail

Forbion raises $1.47bn for two life sciences-focused funds

Pharmaceutical Technology

European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The funds were created to cater to the needs of two distinct segments of the market. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage life sciences companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

XtalPi has entered a strategic partnership with CK Life Sciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). The aim of the alliance is to bring to market precision therapy for patients globally. In September 2020, the company raised funds worth $318.8m

article thumbnail

With biotech in retreat, Third Rock raises $1B for life sciences investing

Bio Pharma Dive

The fund, Third Rock’s sixth, comes amid a significant downturn in the biotech stock market, which has raised questions about the viability of young drug startups.

article thumbnail

Building the dream team: how life science startups can attract top talent

Bio Pharma Dive

Learn how to attract and retain top talent, in an ultra-competitive labor market.

article thumbnail

AstraZeneca Strengthens Canadian Life Sciences Footprint with $570M Investment

XTalks

The expansion will also contribute to building the province of Ontarios position as a global hub for life sciences and biotechnology. The agency said it has also provided the company with site selection services, market intelligence and immigration support to streamline the investment process. million CAD ($11.2

article thumbnail

Life sciences leaders invest in process mining to accelerate digital transformation

Bio Pharma Dive

Research from Everest Group shows how life sciences leaders are investing in process mining to speed time-to-market, improve regulatory compliance and drive innovation.